Fingerprint
Dive into the research topics of 'Multicenter phase II study of irinotecan, cisplatin, and bevacizumab in patients with metastatic gastric or gastroesophageal junction adenocarcinoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically